|
|
|
Corporate Profile: Immunovaccine
| Summary: |
Immunovaccine is focused on the research and development of its patented DepoVax™ vaccine adjuvant platform and products for cancer therapy and infectious diseases.
|
| Address (HQ): |
1344 Summer Street
Suite 412
Halifax, NS
B3H 0A8
Canada |
| Phone #'s (HQ): |
| Main |
(902) 492-1819 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax #'s (HQ): |
| Main |
(902) 492-0888 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| IMV.V |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications mentioning company on PubMed: publications
link. |
|
|
|
